​​Binge Behavior Regulators

​

This family covers the use of aminoindan-derived compounds for regulating binge behavior, including binge drinking. Google Patents shows this family with country-status records in the United States, Europe, China, Denmark, and the international PCT system.

 

Granted patents

United States — US10137096B2
Granted November 27, 2018. Active in Google Patents. This is a core granted U.S. patent in the family.

China — CN107406369B
Shown in Google Patents country status as a Chinese granted record for this family.

 

Published applications and public filings

United States — US20180085326A1
Published application corresponding to the U.S. grant path.

Europe — EP3705469A1
European publication-stage family record shown in country status.

Denmark — DK3230255T3
Danish territorial record shown in country status.

International — WO2016092546A1
PCT publication for the family.

Alcoholic Beverage Substitutes

This family concerns beverage formulations using related neuroactive compounds as substitutes for conventional alcoholic drinks. Google Patents shows country-status records in the United States, Europe, China, and the PCT system.

 

Granted patents

United States — US11528924B2
Shown in Google Patents country status as the granted U.S. record for this family.

Europe — EP3230256B1
European grant, published November 13, 2019 in the family record.

 

Published applications and public filings

Europe — EP3230256A1
European published application.

Europe — EP3230256A4
European publication-stage family record.

China — CN107406370A
Chinese publication-stage record shown in country status.

International — WO2016092547A1
PCT publication for the family.

Use of 3-Methylmethcathinone

This family addresses the use of 3-MMC in drug-assisted psychotherapy. Google Patents shows family records across the United States, Europe, Japan, Australia, Canada, Spain, Finland, Hungary, Poland, Portugal, Slovenia, and the PCT system.

 

Granted patents

Europe — EP3661491B1
European granted record shown in country status.

Japan — JP7273037B2
Japanese granted record shown in country status.

Australia — AU2018309420B2
Australian granted record shown in country status.

Canada — CA3072780C
Canadian granted record shown in country status.

New Zealand — NZ762060B2
New Zealand granted record visible in the family results.

 

Published applications and public filings

United States — US20200360311A1
U.S. published application shown in country status.

Spain — ES3034024T3
Spanish territorial record shown in country status.

Finland — FI3661491T3
Finnish territorial record shown in family records.

Hungary — HUE072199T2
Hungarian territorial record shown in country status.

Poland — PL3661491T3
Polish territorial record shown in country status.

Portugal — PT3661491T
Portuguese territorial record shown in country status.

Slovenia — SI3661491T1
Slovenian territorial record shown in country status.

International — WO2019026019A1
PCT publication for the family.

Treatment of Menstrual Cycle-Induced Symptoms

This family concerns the treatment of menstrual-cycle-induced symptoms using 3-MMC-based therapeutic methods and dosing protocols. Google Patents shows country-status records in seventeen jurisdictions, including the United States, Europe, Japan, Korea, China, Australia, and others.

 

Granted patents

United States — US11559502B2
Granted U.S. record, shown as active in the family listing.

Europe — EP4021433B1
European granted record, shown as active in the family listing.

Australia — AU2020335372B2
Australian granted record shown in the family record.

China — CN114555070B
Chinese granted record shown in the family record.

 

Published applications and public filings

International — WO2021038460A1
PCT publication for the family.

United States — US20220265581A1
U.S. published application.

Korea — KR20220069014A
Korean publication-stage record.

Israel — IL290880A
Israeli publication-stage record.

Brazil — BR112022003686A2
Brazilian publication-stage record.

Croatia — HRP20231735T1
Croatian territorial record shown in the family record.

Mexico — MX2022002400A
Mexican publication-stage record.

2-Fluorodeschloroketamine for Treatment of Depression, Including Treatment-Resistant Depression

This family concerns the use of 2-FDCK in treating depression, including treatment-resistant depression. At present, the verified records visible in Google Patents are publication-stage filings across multiple jurisdictions.

 

Published applications and public filings

United States — US20250032429A1
U.S. published application.

Europe — EP4419092A1
European published application.

Japan — JP2024538015A
Japanese publication-stage record.

Korea — KR20240093579A
Korean publication-stage record.

China — CN118401239A
Chinese publication-stage record.

Australia — AU2022374097A1
Australian publication-stage record.

Canada — CA3233107A1
Canadian publication-stage record.

International — WO2023067505A1
PCT publication for the family.

5-MAPB or 6-APB for Use in Drug-Assisted Psychotherapy

This family concerns the use of 5-MAPB or 6-APB in psychotherapeutic intervention. In the verified Google Patents records, the family currently appears in publication-stage form, with country-status records across six jurisdictions. The PCT family application is marked ceased in the family record.

 

Published applications and public filings

United States — US20240423950A1
U.S. published application.

Europe — EP4412608A1
European published application.

China — CN118076349A
Chinese publication-stage record.

Australia — AU2022360880A1
Australian publication-stage record.

Canada — CA3230288A1
Canadian publication-stage record.

International — WO2023057953A1
PCT publication for the family.

Compositions and Methods for Treating Dyskinesia

This family concerns the treatment of dyskinesia using 3-MMC-based pharmaceutical compositions. In the materials verified so far, the family is visible as a public PCT publication, but I have not yet verified a broader jurisdiction table from Google Patents. The entry below is included because it is clearly present in your search set.

 

Published applications and public filings

International — WO2025022362A1
PCT publication for dyskinesia treatment using 3-MMC-based compositions.

Compositions and Methods for Treating Eating Disorders

This family concerns the treatment of eating disorders using 3-MMC-based pharmaceutical compositions. In the verified Google Patents record so far, the family appears as a pending PCT publication.

 

Published applications and public filings

International — WO2025196662A1
PCT publication. The family record is shown as pending in Google Patents.

 

Closing Note

This page presents a jurisdiction-by-jurisdiction view of a patent portfolio in neuropharmacology and behavioral medicine. Related inventions may recur across multiple territories, but each filing reflects a distinct examination pathway and a separate legal contest. That repetition is not redundancy; it is the visible footprint of patent prosecution across different systems.

​